In November HFPN hosted its inaugural policy summit. The event framed heart failure alongside major policy debates, showcased change leaders in heart failure policy, and highlighted priority topics for heart failure care in 2021 and beyond.
New briefing provides heart failure advocates with actionabl...
15 May 2023
The final advocacy briefing in our From guidelines to action series highlights the opportunities for heart failure advocates to improve care in Germany. ...
Tackling the overlooked epidemic of heart failure in Germany...
04 May 2023
Heart failure is prevalent in Germany, but is under-recognised. Key stakeholders came together at the German Heart Failure Roundtable to discuss the need for policy change and comp...
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca, CSL Vifor, Boehringer Ingelheim and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership .
